Aequs Ltd is a precision component manufacturer based in India with manufacturing capabilities in the Aerospace and Consumer sectorsPrecision components are machined parts produced to specified tolerances and are supplied to OEMs and system integrators. Its product portfolio comprises components for engine systems, landing systems, cargo and interiors, structures, assemblies and turnings for the aerospace clients, as well as products for consumer electronics, plastics and consumer durables. The company has two reportable segments, 'Aerospace' and 'Consumer'. The majority of its revenue comes from the Aerospace segment.
2000
4.5K+
Last FY Revenue $100M
Last FY EBITDA $6.8M
$1.1B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, Aequs reported revenue of $100M and EBITDA of $6.8M.
Aequs expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Aequs valuation multiples based on analyst estimates| NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|
| Revenue | XXX | $100M | XXX | XXX | XXX |
| Gross Profit | XXX | $33.5M | XXX | XXX | XXX |
| Gross Margin | XXX | 33% | XXX | XXX | XXX |
| EBITDA | XXX | $6.8M | XXX | XXX | XXX |
| EBITDA Margin | XXX | 7% | XXX | XXX | XXX |
| EBIT | XXX | -$1.6M | XXX | XXX | XXX |
| EBIT Margin | XXX | -2% | XXX | XXX | XXX |
| Net Profit | XXX | -$11.4M | XXX | XXX | XXX |
| Net Margin | XXX | -11% | XXX | XXX | XXX |
| Net Debt | XXX | $42.0M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Aequs has current market cap of INR 88.2B (or $986M), and EV of INR 96.2B (or $1.1B).
As of December 30, 2025, Aequs's stock price is INR 135 (or $2).
See Aequs trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1.1B | $986M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAequs's trades at 10.7x EV/Revenue multiple, and 157.6x EV/EBITDA.
See valuation multiples for Aequs and 15K+ public compsAs of December 30, 2025, Aequs has market cap of $986M and EV of $1.1B.
Equity research analysts estimate Aequs's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Aequs's P/E ratio is not available.
| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $986M | XXX | $986M | XXX | XXX | XXX |
| EV (current) | $1.1B | XXX | $1.1B | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | 10.7x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | 157.6x | XXX | XXX | XXX |
| EV/EBIT | n/a | XXX | -666.5x | XXX | XXX | XXX |
| EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| P/E | n/a | XXX | -86.2x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | -40.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialAequs's revenue per employee in the last FY averaged $22K, while opex per employee averaged $8K for the same period.
Aequs's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Aequs's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Aequs and other 15K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | 7% | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $22K | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $8K | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 2% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 35% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Jubilant Pharmova | XXX | XXX | XXX | XXX | XXX | XXX |
| Biocon | XXX | XXX | XXX | XXX | XXX | XXX |
| Syngene International | XXX | XXX | XXX | XXX | XXX | XXX |
| Dishman Carbogen Amics | XXX | XXX | XXX | XXX | XXX | XXX |
| Cohance Lifesciences | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Aequs acquired XXX companies to date.
Last acquisition by Aequs was XXXXXXXX, XXXXX XXXXX XXXXXX . Aequs acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 65K+ M&A deals.
Start Free Trial| When was Aequs founded? | Aequs was founded in 2000. |
| Where is Aequs headquartered? | Aequs is headquartered in India. |
| How many employees does Aequs have? | As of today, Aequs has 4.5K+ employees. |
| Is Aequs publicy listed? | Yes, Aequs is a public company listed on NSE. |
| What is the stock symbol of Aequs? | Aequs trades under AEQUS ticker. |
| When did Aequs go public? | Aequs went public in 2025. |
| Who are competitors of Aequs? | Similar companies to Aequs include e.g. Jubilant Pharmova, Biocon, Syngene International, Dishman Carbogen Amics. |
| What is the current market cap of Aequs? | Aequs's current market cap is $986M |
| Is Aequs profitable? | Yes, Aequs is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.